research chemical comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-01-16. Where a claim depends on a specific study, the study is described rather than over-claimed.
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
SR9009 is generally described as poorly soluble in water and more soluble in organic solvents such as dimethyl sulfoxide and ethanol. Stock solutions are commonly prepared in an organic solvent before dilution into an aqueous buffer or vehicle. Precipitation can occur if the organic fraction is reduced too quickly or if the final concentration exceeds the compound's solubility limit. Sonication or gentle warming may aid dissolution in some protocols, but excessive heat can promote degradation. Container material and pH can also influence observed solubility.
For long-term storage, SR9009 is typically kept as a solid at low temperature, protected from moisture and light. Desiccated conditions limit hydrolysis, while opaque containers reduce photochemical breakdown. Solutions are less stable than solids and are often stored frozen in aliquots to avoid repeated freeze-thaw cycles. Stability data are not standardized across all suppliers, so users should rely on certificate-of-analysis information when available. Degradation may appear as color change, precipitate, or decreased chromatographic purity.
Laboratory identification of SR9009 typically relies on chromatographic separation coupled to mass spectrometry, often with ultraviolet detection as a secondary check. Nuclear magnetic resonance spectroscopy can confirm molecular structure when a reference standard is available. Because many suppliers sell the compound as a research chemical, independent identity testing is important for experimental reproducibility. A single retention time is not sufficient proof of identity, especially when related compounds may be present. Purity assessments usually report a percentage based on area normalization.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | SR9009; Stenabolic | Nickname is not a chemical name. |
| Typical analytical method | LC-MS/MS | Often with isotope-labeled internal standard. |
| Storage temperature | -20 °C | Desiccated and protected from light. |
| Solution stability | DMSO stock; avoid freeze-thaw | Store at -20 to -80 °C. |
| Regulatory status | Not approved; varies by country | May be restricted as research chemical. |
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.
SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.
The mechanism of action involves binding to REV-ERB receptors and recruiting corepressor complexes, which represses target gene transcription. This contrasts with many nuclear receptor agonists that activate transcription. Downstream effects may include changes in autophagy, mitochondrial biogenesis, and lipid handling, but the precise pathways remain an active area of study. Whether these molecular events translate into meaningful physiological effects in humans is unresolved. Most evidence comes from cultured cells and rodent models rather than human participants.
SR9009 is a synthetic small molecule developed as an agonist of the nuclear receptors REV-ERBα (NR1D1) and REV-ERBβ (NR1D2). These receptors help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, SR9009 alters transcription of genes involved in lipid metabolism, inflammation, and mitochondrial function. It is not an approved medicine, and its pharmacological profile in humans remains largely uncharacterized. The compound is frequently discussed in the context of circadian biology and metabolic research rather than clinical use.
Preclinical reports have linked SR9009 to improved endurance and altered energy expenditure in rodents. Such findings have prompted interest in whether REV-ERB activation can influence skeletal muscle metabolism. However, the reported effects depend on dose, route, and experimental model, and replication across laboratories is limited. Human trials have not established comparable outcomes, so claims about exercise performance remain speculative. The absence of controlled human data is a central limitation in interpreting these observations.
Tramadol is used primarily to treat mild to severe pain, both acute and chronic. There is moderate evidence for use as a second-line treatment for fibromyalgia, but it is not FDA-approved for this use. Its use is approved for treatment of fibromyalgia as a secondary painkiller by the UK NHS. Its analgesic effects take approximately an hour to be realized, and it takes from two to four hours to reach peak effect after oral administration with an immediate-release formulation. On a dose-by-dose basis, tramadol has about one-tenth the potency of morphine (thus 100 mg is commensurate with 10 mg morphine but may vary) and is practically equally potent when compared with pethidine and codeine. For moderate pain, its effectiveness is roughly equivalent to that of codeine in low doses and hydrocodone at very high doses. For severe pain, it is less effective than morphine. Pain-reducing effects last approximately six hours. The potency of analgesia varies considerably as it depends on an individual's genetics. People with specific variants of CYP2D6 enzymes may not produce adequate amounts of the active metabolite (desmetramadol) for effective pain control.
Usman Yusuf - professor of hematology-oncology and bone marrow transplantation, former chief executive officer of the National Health Insurance Scheme (NHIS). Bello Bako Dambatta - professor of chemistry, vice chancellor Bayero University kano. Aisha Maikudi - professor of international law, vice chancellor University of Abuja, youngest female vice-chancellor at the age of 41. Hadiza Galadanci - professor of obstetrics and gynecology at Bayero University, Kano, director of the World Bank Africa Center of Excellence for Population Health and Policy. Muhammad Yahuza Bello - professor of mathematics, 10th vice-chancellor Bayero University kano Fatima Tahir - professor of microbiology, vice-chancellor of Bauchi State University. Ibrahim Umar (physicist) - professor of physics, 3rd vice chancellor Bayero University kano. Abubakar Sani Sambo - former director-general of Energy Commission of Nigeria (ECN), former vice chancellor of Abubakar Tafawa Balewa University. Mahmud Tukur - first vice chancellor Of Bayero University Kano, former minister of commerce and industry. Aisha Mahmoud Hamman - professor in the Department of Accounting and Finance at Ahmadu Bello University, Zaria Haruna Musa - professor of chemistry, vice-chancellor Bayero University Kano. Abba Gumel - professor & The Michael and Eugenia Brin Endowed E-Nnovate Chair in Mathematics at the Department of Mathematics, University of Maryland. Fatimah Tuggar - professor of AI in Arts, University of Florida.
Honorary Doctorate, California State University, Fullerton (CSUF) (May 2008) NASA Performance Award (2002 & 2001) NASA Go the Extra Mile (GEM) Award (2001) NASA Superior Accomplishment Award (2000) NASA Group Achievement Award – Russian Crusader Team (2000) Camille and Henry Dreyfus Postdoctoral Fellowship in Environmental Science (1997) Outstanding Doctoral Student Award in Chemistry from the University of California, Davis (1997) American Vacuum Society – HWhetten Award (1996) American Vacuum Society Graduate Research Award (1996) Pro Femina Research Consortium Graduate Research Award (1996) Pro Femina Research Consortium Graduate Award for Scientific Travel (1996) University of California, Davis Graduate Research Award (1996) University of California, Davis Graduate Student Award for Scientific Travel (1994) Patricia Roberts Harris Graduate Fellowship in Chemistry (1993–1997) Lyle Wallace Award for Service to the Department of Chemistry, California State University Fullerton (1993) National Science Foundation Research Experience for Undergraduates Award (1992) Council of Building & Construction Trades Scholarship (1991 and 1992) Big West Scholar Athlete (1989–1991)
Upon returning from questioning by the FBI, Eddie and Lily realize that they are being framed after encountering planted evidence in both of their houses. The two flee to an observatory in Wisconsin belonging to Maggie McDermott, an old friend of Eddie's. After resting up, they contact Paul but are almost caught and narrowly escape. As the pair are evading more police, Paul meets with Lyman Earl Collier at the C-Systems Research complex, where it is revealed that C-Systems orchestrated the plot to destroy the laboratory and frame the pair for it, with Lyman ordering the attack. Despite some disagreement, Paul and Lyman decide to continue hunting for the pair, a task facilitated when Eddie covertly arranges a meeting with Paul. At their rendezvous, Paul reveals his involvement in framing Eddie, but the meeting ends in an ambush in which Lyman's thugs Yusef Reed and Clancy Butler, who murdered Alistair, capture Lily while Eddie barely escapes. After tracing the license plate on the thugs' van, Eddie tracks them to the secret C-Systems Research facility where Paul and Lyman are forcing Lily and Chen to replicate the project. When C-Systems' test reactor malfunctions, Paul, the scientists and the prisoners all depart, allowing Eddie to furtively "fix" the system that night. The next morning, one of the other scientists discovers the working reactor and everyone celebrates. A suspicious Paul immediately obtains a download of the fusion data, and secretly gives it to his assistant, Anita, for safekeeping.
Sources: en.wikipedia.org
== Research == Sinclair has expressed the view that there is no limit to human lifespan, and that there is a backup copy of the genetic and epigenetic information in us. While Sinclair was in Guarente's lab, he discovered that sirtuin 1 (called sir2 in yeast) slows aging in yeast by reducing the accumulation of extrachromosomal rDNA circles. Others working in the lab at the time identified NAD as an essential cofactor for sirtuin function. In 2002, after he had left for Harvard, he clashed with Guarente at a scientific meeting at Cold Spring Harbor Laboratory, challenging Guarente's description of how sir2 might be involved in aging; this set off a scientific rivalry. In 2003, Sinclair learned that scientists at a Pennsylvania biotech company called Biomol Research Laboratories had developed a biochemical assays in which they thought that polyphenols including resveratrol activated SIR2. This led to publications authored in part by Sinclair in both Nature and Science in 2003. However, by 2005, it became clear that the biochemical assay consists of a fluorescent probe that interacts nonspecifically with resveratrol and that resveratrol is not a SIR2 activator Despite the scientific debunking of resveratrol, Sinclair maintains an outspoken advocacy for resveratrol as an anti-aging drug and supplement. High-profile papers claiming age reversal of mice have also come under intense scrutiny. Sinclair's lab has continued to work on resveratrol and analogues of it as part of their research program in anti-aging.
transferase Any of a class of enzymes which catalyze the chemical transfer of a functional group or substituent from one molecule to another. For example, acetyltransferases catalyze the movement of an acetyl group in a process known as acetylation; methyltransferases catalyze the movement of one or more methyl groups in a process known as methylation.
By further optimizing the CNTs and CNT fibers, CNT fibers with improved electrical properties could be developed. CNT-based yarns are suitable for applications in energy and electrochemical water treatment when coated with an ion-exchange membrane. Also, CNT-based yarns could replace copper as a winding material. Pyrhönen et al. (2015) have built a motor using CNT winding.
==== Knight/Dame Grand Cross of the Order of the British Empire (GBE) ==== Civil The Right Honourable Dame Margaret Mary Beckett, , Member of Parliament for Derby South. For Parliamentary, Political and Public Service. Professor Dame Carol Mary Black, , Independent Adviser on Combatting Drugs. For Public Service. Sir William Blackledge Beaumont, , Chair, World Rugby. For services to Rugby Union Football and to Charity. Professor Sir James Rufus McDonald, , President, Royal Academy of Engineering. For services to Engineering, to Education and to Energy. Sir Ridley Scott, Director and Producer. For services to the UK Film Industry.
==== Individual droplet addressability ==== DMF allows for droplet level addressability, meaning individual droplets can be treated as spatially distinct microreactors. This level of droplet control is important for workflows where reactions are sensitive to the order of reagent mixing and incubation times, but where the optimal values of these parameters may still need to be determined. These types of workflows are common in cell-free biology, and Liu et al. were able to demonstrate a proof-of-concept DMF-based strategy for carrying out remote-controlled cell-free protein expression on an OpenDrop chip.
Sources: en.wikipedia.org
The most common approach is liquid chromatography-tandem mass spectrometry, often after extraction from blood, urine, or tissue. Ultraviolet detection and nuclear magnetic resonance spectroscopy are used mainly for reference material characterization. Isotope-labeled internal standards improve accuracy.
Solid material is usually kept at -20 °C, desiccated, and protected from light. Dimethyl sulfoxide stocks should be stored cold and subjected to minimal freeze-thaw cycles. Aqueous solutions are generally less stable and should be prepared fresh when possible.
Legality depends on the country and the intended use. It is not an approved medicine, and some places restrict or ban sales for human consumption. Buyers should verify local rules and product documentation before procurement.
Liquid chromatography with mass spectrometry is a common approach. Ultraviolet detection and nuclear magnetic resonance can support identification when suitable standards are available.